Related Experiment Video

Updated: Jul 5, 2026

A Swine Model of Neonatal Asphyxia
10:36

A Swine Model of Neonatal Asphyxia

Published on: October 11, 2011

Management of asymptomatic hypoglycaemia in neonates

1

  • 1jbi@adelaide.edu.au

Nursing Standard (Royal College of Nursing (Great Britain) : 1987)
|May 23, 2008
PubMed

Insights

This review examines feeding strategies and thermoregulation to prevent hypoglycemia in infants. Evidence supports specific feeding types and timing, alongside maintaining body temperature, to manage blood glucose levels effectively.

Area of Science:

  • Neonatal Medicine
  • Pediatric Nutrition
  • Evidence-Based Practice

Background:

  • Hypoglycemia is a common neonatal concern.
  • Previous reviews by WHO (1997a) highlighted knowledge gaps.
  • Further systematic review is needed to consolidate evidence.

Purpose of the Study:

  • To systematically review interventions for preventing hypoglycemia.
  • To evaluate the effectiveness of different feeding types and timing.
  • To assess the role of thermoregulation in preventing hypoglycemia.

Main Methods:

  • Systematic review methodology.
  • Synthesis of data from Hewitt et al (2005).
  • Extension of World Health Organization (WHO) 1997a review.

Main Results:

  • Identified key signs of hypoglycemia.
  • Assessed the efficacy of various feed types for blood glucose control.
  • Determined optimal feeding schedules to prevent hypoglycemia.
  • Evaluated the impact of thermoregulation on hypoglycemia prevention.

Conclusions:

  • Specific feeding strategies and adequate thermoregulation are crucial for preventing neonatal hypoglycemia.
  • Findings provide implications for clinical practice and guide recommendations.
  • Evidence supports proactive management of blood glucose levels in newborns.

More Related Videos

Biochemical Measurement of Neonatal Hypoxia13:13

Biochemical Measurement of Neonatal Hypoxia

Published on: August 24, 2011

Related Concept Videos

Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...